Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints

NCT02238717 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06372865 (65mg)
DRUG: PF-06372865 (15mg)
DRUG: Pregabalin
DRUG: Placebo

Sponsor

Pfizer